Patents by Inventor David T. Connor

David T. Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4012422
    Abstract: The invention relates to novel compounds having the formulas I and III: ##STR1## wherein, in formula I, X is -O- or -N-COR wherein R is lower alkyl or aryl, and Z is ##STR2## WHEREIN R' is hydrogen, halogen or alkoxy. The compounds of this invention are prepared by a novel process which involves the cyclization of the corresponding aryl(methylsulfinyl)methyl ketones. The compounds of this invention having formulas I and III are useful in the treatment of hyperacidity and for alleviating allergic manifestations.
    Type: Grant
    Filed: April 25, 1975
    Date of Patent: March 15, 1977
    Inventors: David T. Connor, Maximilian Von Strandtmann
  • Patent number: 4009261
    Abstract: The present invention relates to 7-substituted triol derivatives of the novel antibiotic substance, acid S, produced by the organism Polyangium cellulosum var. fulvum (ATCC No. 25532) and to processes for their preparation. The 7-substituted triol derivatives of acid S of this invention are useful as antifungal agents.
    Type: Grant
    Filed: August 7, 1975
    Date of Patent: February 22, 1977
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Samuel M. Ringel, Maximilian VON Strandtmann
  • Patent number: 4007205
    Abstract: There are disclosed 7-substituted-9-oxoxanthene-2-carboxaldehydes of the formula: ##STR1## in which R is lower alkoxy or hydroxy. These compounds are indicated in the management of allergic manifestations such as, for example, bronchial asthma or hay fever.
    Type: Grant
    Filed: March 16, 1976
    Date of Patent: February 8, 1977
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Max VON Strandtmann
  • Patent number: 4007193
    Abstract: Substituted 3-(2-pyridinyl)-4-(1H)-quinolinone N-oxides having the formula I: ##STR1## wherein R.sub.1 is hydrogen, halogen, lower alkyl, hydroxy or alkoxy; R.sub.2 is hydrogen or lower alkyl; R.sub.3 is hydrogen or --CH.sub.2 OH; the dotted line indicates the possible presence of a double bond at the 2,3-position of the quinoline ring; the pharmaceutically acceptable acid addition salts thereof; and a process for the preparation thereof, are described. The compounds of the invention are useful for the treatment of hyperacidity and for the prevention of allergic and asthmatic reactions.
    Type: Grant
    Filed: September 8, 1975
    Date of Patent: February 8, 1977
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Patricia A. Young, Maximilian VON Strandtmann
  • Patent number: 4001398
    Abstract: The present invention describes octahydro and decahydro derivatives of the novel antibiotic substance, acid S, produced by the organism Polyangium cellulosum var. fulvum (ATCC No. 25532) and to processes for their preparation. The octahydro and dechydro derivatives of acid S of this invention are useful as antifungal and antibacterial agents.
    Type: Grant
    Filed: June 24, 1974
    Date of Patent: January 4, 1977
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Samuel M. Ringel, Sidney Roemer, Maximilian VON Strandtmann
  • Patent number: 3983237
    Abstract: 2-Aryl substituted isoxazolo[2,3-a]pyridinyl halides having the formula I: ##SPC1##wherein R.sub.1, R.sub.2 and R.sub.3 are each hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy or lower alkanoyl; R.sub.4 is hydrogen or lower alkyl; X is a bromide, chloride or iodide salt; and processes for the preparation thereof, are described. The compounds of the invention are useful as anti-inflammatory agents and for the treatment of hyperacidity.
    Type: Grant
    Filed: September 8, 1975
    Date of Patent: September 28, 1976
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Patricia A. Young, Maximilian VON Strandtmann
  • Patent number: 3973020
    Abstract: 3-(2-Pyridinyl)-4(1H)-cinnolinone N-oxides of the formula I: ##SPC1##wherein R is hydrogen, halogen, lower alkyl, hydroxy or alkoxy; the pharmaceutically acceptable acid addition salts thereof; and a process for the preparation thereof, are described. The compounds of the invention are useful for the treatment of hyperacidity.
    Type: Grant
    Filed: September 8, 1975
    Date of Patent: August 3, 1976
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Patricia A. Young, Maximilian VON Strandtmann
  • Patent number: 3932621
    Abstract: The present invention relates to triols derived from antibiotic substance, designated acid S, produced by Polyangium cellulosum var. fulvum (ATCC No. 25532), to the acetates thereof and to processes for the production of the triols and corresponding acetates. These triols and acetates are potent antifungal agents inhibiting the growth of a variety of fungi, including H. capsulatum, T. mentagrophytes and M. fulvum.
    Type: Grant
    Filed: June 24, 1974
    Date of Patent: January 13, 1976
    Assignees: Max VON Strandtmann, Warner-Lambert Company
    Inventors: David T. Connor, Samuel M. Ringel
  • Patent number: 3932620
    Abstract: The present invention relates to keto and ketoxime derivatives of the novel antibiotic substance, acid S, produced by the microorganism Polyangium cellulosum var. fulvum (ATCC N0. 25532) and to processes for their preparation. The novel keto and ketoxime derivatives of acid S of this invention are useful antifungal agents.
    Type: Grant
    Filed: June 24, 1974
    Date of Patent: January 13, 1976
    Assignee: Warner-Lambert Company
    Inventors: David T. Connor, Samuel M. Ringel, Maximilian VON Strandtmann